Rhonda Patrick, Ph.D.

And we were talking about this urolithin A compound on the drive up here and how that's important for mitochondrial health.

And we're actually going to cover it in the newsletter.

But I'm taking it right now.

And I'm like, it's all, what am I measuring to know if it's really doing anything, right?

I guess VO2 max would be something to measure.

But you have to have good baselines.

And I don't have all that.

So, you know.

Okay.

Well, I want to circle back to sheer stress because that also plays a role in some of the mechanisms behind the reduction in cancer mortality as well.

And that's something that Dr. Carrie Carnier talked about on the podcast.

So, you know, the reductions in...

cancer-related mortality weren't as high as, you know, the type 2 diabetes risk reduction, but they're still significant enough, right?

You're talking 3.5.

For every one minute of vigorous activity, you have to spend 3.5 minutes of, you know, moderate intensity activity, almost four minutes, right?

If you round up, I would say it's almost four minutes.

Why is that the case?

Well, there's probably a lot of, again, mechanisms, but one that I think that's super interesting is

is that sheer stress that's improving your endothelial function, that's improving the function of your arteries and in your blood vessels, it's also playing a role in killing cancer cells.

And you might go, what are you talking about?